Cointime

BioTrove

company

About

Gene Analysis

  • 51 - 100

Highlights

Total Funding Amount
$28.20M
Funding Rounds
4
Investors
3

Details

Last Funding Type
Private Equity（PE）
Last Funding Money Raised
$5.30M
Industries
Biotechnology,Genetics,Health Care,Life Science
Founded date
Jan 1, 1997
Number Of Employee
51 - 100
Operating Status
Active

BioTrove, Inc. provides micro and nano-scale technology platforms for life science and drug discovery research applications. The company offers OpenArray, a technology platform for relative gene expression analysis that advances genomic research in various life science fields, including agriculture, disease research, and public health; RapidFire, a technology platform that enables the screening of intractable drug targets via mass spectrometry based assay development; and RapidFire mass spectrometry hardware system, a native detection technology for drug screening and in vitro ADME applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$28.20M
BioTrove has raised a total of $28.20M in funding over 2 rounds. Their latest funding was raised on Mar 8, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 8, 2006 Series Unknown $7M 1 — — Detail
Jul 16, 2005 Series B $5M 1 — — Detail
Jan 29, 2004 Series B $10.90M 1 — — Detail
Oct 16, 2002 Private Equity（PE） $5.30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
BioTrove is funded by 3 investors. Echelon Ventures and Biofrontier Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Echelon Ventures — Series Unknown
Biofrontier Partners — Series B
BioFrontier Partners — Private Equity（PE）
Cointime
Content
Company